Listed by the USPTO as GOTFREDSON, GAREN
Tech Center 1600 • Art Units: 1615 1619 1626
This examiner grants 40% of resolved cases
GOTFREDSON, GAREN is assigned to tech center 1600 and art unit 1615. The profile reports 550 resolved cases, a 39.8% allowance rate, and a median of 1418 days to allowance. Interview lift is 28.2%, positive and below the overall allowance measure.
The listed companies are Conopco, Inc. d/b/a Unilever, Novartis AG, and The Procter & Gamble Company. The listed firms are AMPACC Law Group, PLLC, BIRCH STEWART KOLASCH & BIRCH, LLP, and Byrne Poh LLP. The case volume supports meaningful examiner-level planning. Given the lower allowance result and extended median duration, counsel may benefit from early claim strategy and interview preparation, while maintaining alternatives for continued prosecution.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18261523 | PHARMACEUTICAL COMPOSITION | Final Rejection | Novartis AG |
| 18472478 | HAIR CARE COMPOSITIONS COMPRISING A 2-PYRIDINOL-N-OXIDE MATERIAL AND AN IRON CHELATOR | Final Rejection | The Procter & Gamble Company |
| 17126387 | AZOXYSTROBIN EFFICACY IN PERSONAL CARE FORMS | Final Rejection | The Procter & Gamble Company |
| 17621142 | DEVICE FOR DELIVERING A FLOWABLE TISSUE DRESSING MATERIAL AND METHODS OF USE | Final Rejection | Solventum Intellectual Properties Company |
| 18348787 | DENSIFIED CO-PRECIPITATED MATERIALS ISOLATED BY THIN FILM EVAPORATION | Final Rejection | Merck Sharp & Dohme LLC |
| 17768677 | ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN | Non-Final OA | SYMRISE AG |
| 17772897 | SUN CARE COMPOSITIONS WITH HOLLOW MESOPOROUS SILICA NANOSPHERES | Non-Final OA | ROHM AND HAAS COMPANY |
| 18723269 | SYNTHETIC BIOPOLYMERS AND THEIR USE IN COMPOSITIONS FOR TISSUE REPAIR | Non-Final OA | DSM IP ASSETS B.V. |
| 18011643 | ADJUVANTS | Final Rejection | GLAXOSMITHKLINE BIOLOGICALS SA |
| 18571083 | CONTINOUS IMPREGNATION OF ACTIVE PHARMACEUTICAL INGREDIENTS ONTO POROUS CARRIERS | Final Rejection | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY |
| 17642829 | FLYING PEST CONTROL COMPOSITION AND FLYING PEST CONTROL SPRAY | Non-Final OA | Kao Corporation |
| 18706245 | HYDRATABLE CONCENTRATED SURFACTANT COMPOSITIONS | Final Rejection | Conopco, Inc., d/b/a Unilever |
| 17615222 | PERSONAL CLEANSING COMPOSITIONS | Final Rejection | CONOPCO, INC.,D/B/A UNILEVER |
| 18692081 | POWDER COSMETIC | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 17611338 | METHODS FOR ENCAPSULATION | Final Rejection | Chr. Hansen A/S |
| 17768166 | TARGETED BIFUNCTIONAL DEGRADERS | Final Rejection | YALE UNIVERSITY |
| 17597703 | MULTILAYER SHEET | Final Rejection | Eastman Chemical Company |
| 17309195 | Deodorant Compositions | Final Rejection | Colgate-Palmolive Company |
| 18230227 | USE OF BETA-1,3-GLUCAN FOR MODULATING IMMUNE FUNCTION AND TREATING INTESTINAL INFLAMMATION | Non-Final OA | KEMIN INDUSTRIES, INC. |
| 18176294 | TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR | Non-Final OA | Incyte Corporation |
| 17422346 | IMPROVEMENT IN OR RELATING TO ORGANIC COMPOUNDS | Final Rejection | GIVAUDAN SA |
| 18574435 | AMINO ACID SCALP AND HAIR CARE COMPOSITION, SCALP AND HAIR CARE PRODUCT CONTAINING SAID COMPOSITION AND PREPARATION METHOD | Non-Final OA | NANJING HUASHI NEW MATERIAL CO., LTD |
| 18214690 | PERSONAL CARE DEODORANT PRODUCT VOID OF ENDOCRINE DISTRUPTING CHEMICALS | Final Rejection | thinkOperations, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy39.8% of resolved applications examined by Garen Gotfredson were allowed (550 resolved cases), compared with 43.8% across Art Unit 1615 over the last five years.
This examiner's interview lift is +28.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Garen Gotfredson took 1,418 days on average from filing to allowance.
Garen Gotfredson examines applications in Art Unit 1615 in Tech Center 1600 (Biotechnology & Pharmaceuticals).